Afyx Development A/S: Financial statements 2025
CVR: 35839739
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Afyx Development A/S (CVR 35839739) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity in the 2025 report amounted to DKK -7,253,987. The company had 3 employees in the financial year.
- Gross Profit
- DKK -5,044,782
- Profit/Loss
- DKK -4,260,251
- Equity
- DKK -7,253,987
- Total Assets
- DKK 3,710,641
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -5 mio. | -4.3 mio. | -7.3 mio. | 3 |
| 2024 | - | -8.4 mio. | -6.9 mio. | -3 mio. | 1 |
| 2023 | - | -4.7 mio. | -10 mio. | 2.4 mio. | 3 |
| 2022 | - | -8.6 mio. | -24.3 mio. | -112.3 mio. | 3 |
| 2021 | - | -27.4 mio. | -35 mio. | -88 mio. | 6 |
Official annual report
How creditworthy is Afyx Development A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Afyx Development A/S has published its annual report for 2024. Gross profit came to DKK -8,423,909, and the net result was DKK -6,896,490.
As of February 26, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Afyx Development A/S.
As of February 26, 2025, GILFELT REVISION REGISTRERET REVISIONSANPARTSSELSKAB has stepped down as auditor of Afyx Development A/S.
As of February 26, 2025, Søren Mohrsen Kjær has joined the board of directors of Afyx Development A/S.
About Afyx Development A/S
Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The board consists of Ole Baadsgaard (chair), Claus Juan Møller-San Pedro, Pia Leah Møller-San Pedro and Søren Mohrsen Kjær. The company is owned by Afyx Therapeutics A/S. The company has 8 employees (2018). In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity in the 2025 report amounted to DKK -7,253,987.